{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:04:06Z","timestamp":1779721446073,"version":"3.53.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The COVID-19 pandemic affected healthcare worldwide. This study analysed age-standardised incidence rates (ASIR) of colorectal cancer (CRC) in Bavaria to assess the COVID-19 pandemic\u2019s impact. We modelled CRC ASIR, overall and in the subgroups (sex, age group, site and stage), in the pre-pandemic (01\/2007 to 02\/2020) and pandemic (03\/2020 to 02\/2022) periods using interrupted time-series analyses. Predictions for the third year of the pandemic (03\/2022 to 02\/2023) were compared to expected ASIR. Comparing expected and observed CRC ASIR during the first year of the pandemic showed a significant relative change of -8.8% (95% CI: -12.7% to -4.6%), improving to 1.4% (95% CI: -4.5% to 7.2%) in the third year of the pandemic. Likewise, ASIR significantly decreased across almost all subgroups during the first year of the pandemic, recovering during the second and the third year of the pandemic. Early stages showed a significant estimated reduction, persisting until the third year of the pandemic (-4.7%; 95% CI: -8.6% to -0.9%). In contrast, for women aged 70 years and above and women with colon cancer, ASIR experienced a significant excess. In the first year of the pandemic, estimated CRC ASIR experienced significant decline, returning to the expected rates during the third year of the pandemic, for most, but not all subgroups. The relative difference remained significantly negative for early stages. A significant catch-up effect occurred in the subgroups of women aged 70 years and above and women with colon cancer. Overall, estimations indicate a recovery of CRC ASIR.<\/jats:p>","DOI":"10.1038\/s41598-026-51701-w","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:14:07Z","timestamp":1779718447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Colorectal cancer incidence before and during the COVID-19 pandemic: a non-linear interrupted time-series analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Nina","family":"Grundmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Hakimhashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Voigtl\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"M\u00fcller-Nordhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"51701_CR1","doi-asserted-by":"crossref","unstructured":"Jacob, L. et al. Impact of the COVID-19 pandemic on cancer diagnoses in general and specialized practices in Germany. Cancers (Basel) 13 (2021).","DOI":"10.3390\/cancers13030408"},{"key":"51701_CR2","doi-asserted-by":"publisher","first-page":"100543","DOI":"10.1016\/j.lanepe.2022.100543","volume":"23","author":"H Brenner","year":"2022","unstructured":"Brenner, H., Cardoso, R., Heisser, T., Hoffmeister, M. & Holleczek, B. Indications of substantial delay of colorectal cancer diagnoses due to COVID-19 in Germany. Lancet Reg. Health Eur. 23, 100543 (2022).","journal-title":"Lancet Reg. Health Eur."},{"key":"51701_CR3","doi-asserted-by":"publisher","first-page":"100197","DOI":"10.1016\/j.esmoop.2021.100197","volume":"6","author":"HM Peacock","year":"2021","unstructured":"Peacock, H. M. et al. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis. ESMO Open. 6, 100197 (2021).","journal-title":"ESMO Open."},{"key":"51701_CR4","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S1470-2045(21)00426-5","volume":"22","author":"ZJ Ward","year":"2021","unstructured":"Ward, Z. J. et al. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis. Lancet Oncol. 22, 1427\u20131437 (2021).","journal-title":"Lancet Oncol."},{"key":"51701_CR5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","volume":"21","author":"C Maringe","year":"2020","unstructured":"Maringe, C. et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 21, 1023\u20131034 (2020).","journal-title":"Lancet Oncol."},{"key":"51701_CR6","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S1470-2045(20)30392-2","volume":"21","author":"A Sud","year":"2020","unstructured":"Sud, A. et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 21, 1035\u20131044 (2020).","journal-title":"Lancet Oncol."},{"key":"51701_CR7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.annonc.2020.05.009","volume":"31","author":"A Sud","year":"2020","unstructured":"Sud, A. et al. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann. Oncol. 31, 1065\u20131074 (2020).","journal-title":"Ann. Oncol."},{"key":"51701_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1200\/GO.20.00639","volume":"7","author":"R Riera","year":"2021","unstructured":"Riera, R. et al. Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review. JCO Glob Oncol. 7, 311\u2013323 (2021).","journal-title":"JCO Glob Oncol."},{"key":"51701_CR9","doi-asserted-by":"crossref","unstructured":"Hanna Mortality due to cancer treatment delay: systematic review and meta-analysis. (2020).","DOI":"10.1136\/bmj.m4087"},{"key":"51701_CR10","doi-asserted-by":"crossref","unstructured":"Mangone, L. et al. The Influence of COVID-19 on New Lung Cancer Diagnoses, by Stage and Treatment, in Northern Italy. Biology (Basel). 12 (2023).","DOI":"10.3390\/biology12030390"},{"key":"51701_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S2468-1253(21)00005-4","volume":"6","author":"EJA Morris","year":"2021","unstructured":"Morris, E. J. A. et al. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. Lancet Gastroenterol. Hepatol. 6, 199\u2013208 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"51701_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1470-2045(23)00293-0","volume":"24","author":"X Han","year":"2023","unstructured":"Han, X. et al. Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment. Lancet Oncol. 24, 855\u2013867 (2023).","journal-title":"Lancet Oncol."},{"key":"51701_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/jamaoncol.2023.6969","volume":"10","author":"T Burus","year":"2024","unstructured":"Burus, T. et al. Undiagnosed Cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic. JAMA Oncol. 10, 500\u2013507 (2024).","journal-title":"JAMA Oncol."},{"key":"51701_CR14","doi-asserted-by":"publisher","first-page":"e2017267","DOI":"10.1001\/jamanetworkopen.2020.17267","volume":"3","author":"HW Kaufman","year":"2020","unstructured":"Kaufman, H. W., Chen, Z., Niles, J. & Fesko, Y. Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic. JAMA Netw. Open. 3, e2017267 (2020).","journal-title":"JAMA Netw. Open."},{"key":"51701_CR15","doi-asserted-by":"publisher","first-page":"e1257","DOI":"10.1016\/S2214-109X(22)00285-6","volume":"10","author":"H Kiarie","year":"2022","unstructured":"Kiarie, H. et al. The COVID-19 pandemic and disruptions to essential health services in Kenya: a retrospective time-series analysis. Lancet Glob Health. 10, e1257\u2013e1267 (2022).","journal-title":"Lancet Glob Health"},{"key":"51701_CR16","doi-asserted-by":"publisher","first-page":"E804","DOI":"10.1503\/cmaj.221512","volume":"195","author":"E Heer","year":"2023","unstructured":"Heer, E. et al. Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta. CMAJ 195, E804\u2013E812 (2023).","journal-title":"CMAJ"},{"key":"51701_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00761-023-01444-4","volume":"30","author":"K Kraywinkel","year":"2024","unstructured":"Kraywinkel, K., Imhoff, M., Voigtl\u00e4nder, S. & Stang, A. Cancer incidence in pandemic times. Results from German cancer registries for the diagnostic year 2020 [Krebsneuerkrankungen in Pandemiezeiten. Ergebnisse aus deutschen Krebsregistern f\u00fcr das Diagnosejahr 2020]. Onkologie 30, 265\u2013272. https:\/\/doiorg\/101007\/s00761-023-01444-4 (2024).","journal-title":"Onkologie"},{"key":"51701_CR18","doi-asserted-by":"publisher","first-page":"7493","DOI":"10.1007\/s00432-023-04707-0","volume":"149","author":"S Voigtlander","year":"2023","unstructured":"Voigtlander, S. et al. Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany. J. Cancer Res. Clin. Oncol. 149, 7493\u20137503 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"51701_CR19","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1002\/ijc.32566","volume":"146","author":"F Guo","year":"2020","unstructured":"Guo, F. et al. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study. Int. J. Cancer. 146, 2423\u20132432 (2020).","journal-title":"Int. J. Cancer"},{"key":"51701_CR20","unstructured":"World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) (2019). https:\/\/www.icdwhoint\/browse10\/2019\/en"},{"key":"51701_CR21","unstructured":"Stegmaier, C., Hofst\u00e4dter, H. S., Katalinic, F., Tillack, A. & Klinkhammer-Schalke, A. (Hrsg.) M,. Das Manual der Krebsregistrierung. M\u00fcnchen (Zuckerschwerdt-Verlage, 2019) https:\/\/www.gekid.de\/manual-der-krebsregistrierung;. Accessed on 28.07. 2021."},{"key":"51701_CR22","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1055\/a-1009-6466","volume":"82","author":"V Arndt","year":"2020","unstructured":"Arndt, V. et al. Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives. Gesundheitswesen 82, S62\u2013S71 (2020).","journal-title":"Gesundheitswesen"},{"key":"51701_CR23","first-page":"3","volume":"10","author":"J Schilling","year":"2022","unstructured":"Schilling, J., Buda, S. & Tolksdorf, K. Zweite Aktualisierung der Retrospektiven Phaseneinteilung der COVID-19- Pandemie in Deutschland. DOI 10.25646\/9787. Epid Bull. 10, 3\u20135 (2022).","journal-title":"Epid Bull."},{"key":"51701_CR24","doi-asserted-by":"crossref","unstructured":"Doll, R. C. P. Summarizing indices for comparison of cancer incidence data. Int J Cancer 2, 269\u2013279 (1967).","DOI":"10.1002\/ijc.2910020310"},{"key":"51701_CR25","unstructured":"Wood, S., Mixed & GAM Computation Vehicle with Automatic Smoothness Estimation. GAMM. ; (2023). Available: https:\/\/cran.r-project.org\/web\/packages\/mgcv\/mgcv.pdf; accessed on 06th 05 2024."},{"key":"51701_CR26","unstructured":"ACF. Companion to Tsay Analysis of Financial Time Series. R Documentation. Package FinTS version 0.4-9. (2005). https:\/\/search.r-project.org\/CRAN\/refmans\/FinTS\/html\/Acf.html; accessed on 06th 05 2024."},{"key":"51701_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2021.11.008","volume":"161","author":"E Toes-Zoutendijk","year":"2022","unstructured":"Toes-Zoutendijk, E. et al. Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands. Eur. J. Cancer. 161, 38\u201343 (2022).","journal-title":"Eur. J. Cancer"},{"key":"51701_CR28","doi-asserted-by":"publisher","first-page":"e2332363","DOI":"10.1001\/jamanetworkopen.2023.32363","volume":"6","author":"KM Decker","year":"2023","unstructured":"Decker, K. M. et al. New Cancer Diagnoses Before and During the COVID-19 Pandemic. JAMA Netw. Open. 6, e2332363 (2023).","journal-title":"JAMA Netw. Open."},{"key":"51701_CR29","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.1002\/cam4.5389","volume":"12","author":"AV Ramanakumar","year":"2023","unstructured":"Ramanakumar, A. V. et al. Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada. Cancer Med. 12, 6260\u20136269 (2023).","journal-title":"Cancer Med."},{"key":"51701_CR30","doi-asserted-by":"publisher","first-page":"e2439263","DOI":"10.1001\/jamanetworkopen.2024.39263","volume":"7","author":"U Kim","year":"2024","unstructured":"Kim, U. et al. Recovery From COVID-19-Related Disruptions in Cancer Detection. JAMA Netw. Open. 7, e2439263 (2024).","journal-title":"JAMA Netw. Open."},{"key":"51701_CR31","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/jnci\/djad086","volume":"115","author":"AB Mariotto","year":"2023","unstructured":"Mariotto, A. B. et al. Interpreting cancer incidence trends: challenges due to the COVID-19 pandemic. J. Natl. Cancer Inst. 115, 1109\u20131111 (2023).","journal-title":"J. Natl. Cancer Inst."},{"key":"51701_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/ajcp\/aqaa177","volume":"155","author":"G Ferrara","year":"2021","unstructured":"Ferrara, G. et al. Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic. Am. J. Clin. Pathol. 155, 64\u201368 (2021).","journal-title":"Am. J. Clin. Pathol."},{"key":"51701_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/jnci\/djad205","volume":"116","author":"N Howlader","year":"2024","unstructured":"Howlader, N. et al. Cancer and COVID-19: US cancer incidence rates during the first year of the pandemic. J. Natl. Cancer Inst. 116, 208\u2013215 (2024).","journal-title":"J. Natl. Cancer Inst."},{"key":"51701_CR34","doi-asserted-by":"publisher","first-page":"1370862","DOI":"10.3389\/fonc.2024.1370862","volume":"14","author":"NL Barclay","year":"2024","unstructured":"Barclay, N. L. et al. The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study. Front. Oncol. 14, 1370862 (2024).","journal-title":"Front. Oncol."},{"key":"51701_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2340\/1651-226X.2025.42079","volume":"64","author":"A Johansson","year":"2025","unstructured":"Johansson, A. et al. Changes in cancer incidence and stage during the COVID-19 pandemic in 2020\u20132021 in the Nordic countries. Acta Oncol. 64, 257\u2013266 (2025).","journal-title":"Acta Oncol."},{"key":"51701_CR36","doi-asserted-by":"publisher","first-page":"684032","DOI":"10.3389\/fmed.2021.684032","volume":"8","author":"MS Jordens","year":"2021","unstructured":"Jordens, M. S. et al. Impact of the COVID-19 Pandemic on Consultations and Diagnoses in Gastroenterology Practices in Germany. Front. Med. (Lausanne). 8, 684032 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"51701_CR37","doi-asserted-by":"publisher","first-page":"e043828","DOI":"10.1136\/bmjopen-2020-043828","volume":"10","author":"AG Lai","year":"2020","unstructured":"Lai, A. G. et al. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open. 10, e043828 (2020).","journal-title":"BMJ Open."},{"key":"51701_CR38","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.3390\/ijerph17165974","volume":"17","author":"K Romero Starke","year":"2020","unstructured":"Romero Starke, K. et al. The age-related risk of severe outcomes due to COVID-19 infection: a rapid review, meta-analysis, and meta-regression. Int. J. Environ. Res. public. health Int J. Environ. Res. Public. Health. 17, 5974 (2020).","journal-title":"Int. J. Environ. Res. public. health Int J. Environ. Res. Public. Health"},{"key":"51701_CR39","unstructured":"European Commission. Cancer Screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. Brussels (2017)."},{"key":"51701_CR40","unstructured":"European Commission. European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis - First Edition (2010)."},{"key":"51701_CR41","unstructured":"Bundesausschuss., G. Richtlinie des Gemeinsamen Bundesausschusses f\u00fcr organisierte Krebsfr\u00fcherkennungsprogramme. (2025). Available: https:\/\/www.g-ba.de\/downloads\/62-492-3860\/oKFE-RL-2025-05-15-iK-2025-07-22.pdf; accessed on: 03.11.2025."},{"key":"51701_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13045-020-00984-1","volume":"13","author":"AG Dinmohamed","year":"2020","unstructured":"Dinmohamed, A. G. et al. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands. J. Hematol. Oncol. 13, 147 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"51701_CR43","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1470-2045(21)00199-6","volume":"22","author":"R Cardoso","year":"2021","unstructured":"Cardoso, R. et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 22, 1002\u20131013 (2021).","journal-title":"Lancet Oncol."},{"key":"51701_CR44","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1136\/gutjnl-2017-315111","volume":"67","author":"E Toes-Zoutendijk","year":"2018","unstructured":"Toes-Zoutendijk, E. et al. Stage distribution of screen-detected colorectal cancers in the Netherlands. Gut 67, 1745\u20131746 (2018).","journal-title":"Gut"},{"key":"51701_CR45","doi-asserted-by":"crossref","unstructured":"Cardoso, R., Guo, F., Heisser, T., Hoffmeister, M. & Brenner, H. Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey. Cancers (Basel). 12 (2020).","DOI":"10.3390\/cancers12061409"},{"key":"51701_CR46","unstructured":"Dr\u00e4ther, H., Tillmanns, H., Eymers, E. & Schillinger, S. F. Inanspruchnahme von Krebs-Fr\u00fcherkennungsleistungen der GKV. (2023). https:\/\/www.wido.de\/fileadmin\/Dateien\/Dokumente\/Forschung_Projekte\/Ambulante_Versorgung\/wido_amb_frueherkennungsmonitor_2023.pdf; accessed on 27th 05 2024."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51701-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51701-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51701-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:26:08Z","timestamp":1779719168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51701-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51701"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51701-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16147"}}